Skip to content
ClinCalc Pro
Menu
Renal / Nephrology General Medicine Pharmacology Standard for drug dosing

Creatinine Clearance (Cockcroft-Gault)

Estimates creatinine clearance for weight-based drug dosing (not for CKD staging).

Used in: Chronic Kidney Disease

Use Actual Body Weight (ABW). Use Ideal Body Weight (IBW) if obese.

How to use & interpret

The Cockcroft–Gault equation estimates creatinine clearance (an absolute value in mL/min) from age, weight, sex and serum creatinine. Unlike eGFR, it is not normalised to body surface area, which matters for certain drugs.

It remains the reference for dosing several narrow-therapeutic-index and renally-cleared drugs (notably the DOACs, aminoglycosides and some chemotherapy), and at extremes of body weight. Choose the appropriate body weight (ideal or adjusted in obesity) and remember it is unreliable in unstable renal function.

Score interpretation

Normal / Mildly Reduced ≥ 60

CrCl ≥60 ml/min: Full-dose renal dosing for most drugs. Normal drug clearance.

→ Standard drug dosing. Verify individual drug SPCs for dose adjustments.

Moderate Reduction 30–59.9

CrCl 30–59 ml/min: Dose reduction required for many renally cleared drugs.

→ Halve dose or extend interval for renally cleared drugs (e.g. dabigatran, metformin, LMWH, antibiotics). Check individual drug SPC.

Severe Reduction 15–29.9

CrCl 15–29 ml/min: Significant dose reductions. Many drugs contraindicated.

→ Avoid: metformin, NSAIDs, direct oral anticoagulants (most). Check dose: LMWH, antibiotic regimens. Nephrology review.

Kidney Failure 0–14.9

CrCl < 15 ml/min: Near-dialysis range. Most renally cleared drugs contraindicated.

→ Nephrology review. Most renally excreted drugs contraindicated or need major dose reduction.

Interpretation bands for the CrCl (C-G). Apply clinical judgement and local guidance.

Frequently asked questions

Cockcroft–Gault or eGFR for drug dosing?

Follow the drug's labelling: many DOACs and nephrotoxic drugs are dosed by absolute Cockcroft–Gault creatinine clearance, whereas most general dosing now uses CKD-EPI eGFR. When they disagree at extremes of size, the drug-specific method wins.

References

Related

Curated clinical cross-links plus same-class fallbacks.

Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.